MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-11045

  1. 6,742 Posts.
    lightbulb Created with Sketch. 1458
    @col69, just saw this tweet from Canada. FDA need to approve remestemcel-l … zero safety concerns. Proven efficacy. The vaccines are not working fast enough. The US is a basket case & only getting worse.

    https://hotcopper.com.au/data/attachments/3568/3568618-e12ef2601908fb427becc39014a40ad0.jpg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.